1. Home
  2. MANE vs PAHC Comparison

MANE vs PAHC Comparison

Compare MANE & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MANE

Veradermics Incorporated Common Stock

N/A

Current Price

$108.08

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$40.29

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MANE
PAHC
Founded
2019
1946
Country
United States
United States
Employees
N/A
2475
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MANE
PAHC
Price
$108.08
$40.29
Analyst Decision
Strong Buy
Hold
Analyst Count
4
4
Target Price
$83.33
$41.25
AVG Volume (30 Days)
705.8K
270.6K
Earning Date
03-30-2026
05-06-2026
Dividend Yield
N/A
0.91%
EPS Growth
N/A
1883.33
EPS
N/A
1.90
Revenue
N/A
$833,350,000.00
Revenue This Year
N/A
$17.03
Revenue Next Year
N/A
$3.82
P/E Ratio
N/A
$23.08
Revenue Growth
N/A
4.12
52 Week Low
$36.26
$22.71
52 Week High
$117.71
$60.08

Technical Indicators

Market Signals
Indicator
MANE
PAHC
Relative Strength Index (RSI) 68.23 29.00
Support Level $54.23 $37.87
Resistance Level N/A $41.62
Average True Range (ATR) 10.02 3.03
MACD 1.54 -1.43
Stochastic Oscillator 81.29 5.89

Price Performance

Historical Comparison
MANE
PAHC

About MANE Veradermics Incorporated Common Stock

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: